4D Molecular Therapeutics Inc
FDMT7.970USD
-0.130-1.60%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
372.77MMarket Cap
LossP/E TTM
4D Molecular Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
37.00K
-99.82%
EPS(YoY)
-2.98
-15.72%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its total revenue reached 37.00K, with a year-on-year change of -99.82%.
What is the Earnings Per Share (EPS) of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.982, with a year-on-year change of -15.72%.
What is the net income of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its net income was -160.87M, with a year-on-year change of -59.53%.
What is the net margin of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its net profit margin was -434778.38%, with a year-on-year change of -89251.25%.
What is the gross margin of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -39.31%, with a year-on-year change of -5.10%.
What is the Return on Assets (ROA) of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -35.74%, with a year-on-year change of -6.63%.
What is the operating profit of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its operating profit was -187.84M, with a year-on-year change of -66.43%.
What are the current assets of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its current assets were 434.93M, with a year-on-year change of 46.65%.
What are the total assets of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its total assets of 4D Molecular Therapeutics Inc were 560.38M, with a year-on-year change of 64.87%.
What are the total liabilities of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its total liabilities of 4D Molecular Therapeutics Inc were 49.78M, with a year-on-year change of 55.26%.
What is the total equity of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its total equity of 4D Molecular Therapeutics Inc was 510.61M, with a year-on-year change of 65.87%.
What is the net operating income of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its net operating income of 4D Molecular Therapeutics Inc was -160.87M, with a year-on-year change of -59.53%.
What is the net investment of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its net investment of 4D Molecular Therapeutics Inc was -302.44M, with a year-on-year change of -361.36%.
What is the net financing of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2024 earnings report, its net financing of 4D Molecular Therapeutics Inc was 337.25M, with a year-on-year change of 115.04%.
